A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
Status:
Not yet recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
A Phase IIa open label study evaluating the preliminary efficacy of intratumoural tigilanol
tiglate in advanced and/or metastatic soft tissue sarcoma of the extremities and body wall.